Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones
- PMID: 16141268
- PMCID: PMC1464203
- DOI: 10.1113/jphysiol.2005.095554
Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones
Abstract
NMDA receptors regulate burst firing of dopaminergic neurones in the substantia nigra pars compacta (SNc) and may contribute to excitotoxic cell death in Parkinson's disease (PD). In order to investigate the subunit composition of functional NMDA receptors in identified rat SNc dopaminergic neurones, we have analysed the properties of individual NMDA receptor channels in outside-out patches. NMDA (100 nm) activated channels corresponding to four chord conductances of 18, 30, 41 and 54 pS. Direct transitions were observed between all conductance levels. Between 18 pS and 41 pS conductance levels, direct transitions were asymmetric, consistent with the presence of NR2D-containing NMDA receptors. Channel activity in response to 100 nm or 200 microm NMDA was not affected by zinc or TPEN (N,N,N',N'-tetrakis-[2-pyridylmethyl]-ethylenediamine), indicating that SNc dopaminergic neurones do not contain functional NR2A subunits. The effect of the NR2B antagonist ifenprodil was complex: 1 microm ifenprodil reduced open probability, while 10 microm reduced channel open time but had no effect on open probability of channels activated by 100 nm NMDA. When the concentration of NMDA was increased to 200 microm, ifenprodil (10 microm) produced the expected reduction in open probability. These results indicate that NR2B subunits are present in SNc dopaminergic neurones. Taken together, these findings indicate that NR2D and NR2B subunits form functional NMDA receptor channels in SNc dopaminergic neurones, and suggest that they may form a triheteromeric NMDA receptor composed of NR1/NR2B/NR2D subunits.
Figures
Similar articles
-
NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones.J Physiol. 2008 Feb 1;586(3):739-50. doi: 10.1113/jphysiol.2007.144618. Epub 2007 Nov 22. J Physiol. 2008. PMID: 18033813 Free PMC article.
-
Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.Eur J Neurosci. 2010 Aug;32(3):359-67. doi: 10.1111/j.1460-9568.2010.07298.x. Epub 2010 Jul 6. Eur J Neurosci. 2010. PMID: 20618827 Free PMC article.
-
Subtypes of NMDA receptors in new-born rat hippocampal granule cells.J Physiol. 2002 May 15;541(Pt 1):41-64. doi: 10.1113/jphysiol.2001.014001. J Physiol. 2002. PMID: 12015419 Free PMC article.
-
Subunit- and site-specific pharmacology of the NMDA receptor channel.Prog Neurobiol. 1999 Oct;59(3):279-98. doi: 10.1016/s0301-0082(99)00007-6. Prog Neurobiol. 1999. PMID: 10465381 Review.
-
Structure, function, and pharmacology of NMDA receptor channels.Physiol Res. 2014;63(Suppl 1):S191-203. doi: 10.33549/physiolres.932678. Physiol Res. 2014. PMID: 24564659 Review.
Cited by
-
Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.J Physiol. 2019 Nov;597(22):5495-5514. doi: 10.1113/JP278168. Epub 2019 Nov 2. J Physiol. 2019. PMID: 31541561 Free PMC article.
-
Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.J Neurosci. 2023 Nov 15;43(46):7730-7744. doi: 10.1523/JNEUROSCI.1955-22.2023. Epub 2023 Sep 19. J Neurosci. 2023. PMID: 37726169 Free PMC article.
-
Modulating inhibitory response control through potentiation of GluN2D subunit-containing NMDA receptors.Neuropharmacology. 2020 Aug 15;173:107994. doi: 10.1016/j.neuropharm.2020.107994. Epub 2020 Feb 11. Neuropharmacology. 2020. PMID: 32057801 Free PMC article.
-
NMDA Receptors in the Central Nervous System.Methods Mol Biol. 2017;1677:1-80. doi: 10.1007/978-1-4939-7321-7_1. Methods Mol Biol. 2017. PMID: 28986865 Free PMC article.
-
Influence of GluN2 subunit identity on NMDA receptor function.Neuropharmacology. 2013 Nov;74:4-17. doi: 10.1016/j.neuropharm.2013.01.016. Epub 2013 Jan 31. Neuropharmacology. 2013. PMID: 23376022 Free PMC article. Review.
References
-
- Albers DS, Weiss SW, Iadarola MJ, Standaert DG. Immunohistochemical localization of N-methyl-d-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat. Neuroscience. 1999;89:209–220. - PubMed
-
- Blanchet PJ, Konitsiotis S, Whittemore ER, Zhou ZL, Woodward RM, Chase TN. Differing effects of N-methyl-d-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. J Pharmacol Exp Ther. 1999;290:1034–1040. - PubMed
-
- Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000;62:63–88. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous